A detailed history of Stifel Financial Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Stifel Financial Corp holds 68,421 shares of CORT stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,421
Previous 77,239 11.42%
Holding current value
$2.72 Million
Previous $1.95 Million 14.24%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$22.21 - $34.48 $195,847 - $304,044
-8,818 Reduced 11.42%
68,421 $2.22 Million
Q1 2024

May 13, 2024

BUY
$21.1 - $27.46 $413,454 - $538,078
19,595 Added 33.99%
77,239 $1.95 Million
Q4 2023

Feb 12, 2024

SELL
$24.82 - $32.88 $29,560 - $39,160
-1,191 Reduced 2.02%
57,644 $1.87 Million
Q3 2023

Nov 13, 2023

BUY
$21.97 - $33.8 $31,241 - $48,063
1,422 Added 2.48%
58,835 $1.6 Million
Q2 2023

Aug 14, 2023

BUY
$21.44 - $25.15 $47,168 - $55,330
2,200 Added 3.98%
57,413 $1.28 Million
Q1 2023

May 12, 2023

BUY
$19.2 - $24.47 $393,888 - $502,002
20,515 Added 59.12%
55,213 $1.2 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $115,550 - $173,528
5,792 Added 20.04%
34,698 $704,000
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $73,062 - $86,136
2,958 Added 11.4%
28,906 $741,000
Q2 2022

Aug 15, 2022

BUY
$17.33 - $25.3 $44,364 - $64,768
2,560 Added 10.95%
25,948 $617,000
Q1 2022

May 13, 2022

BUY
$16.53 - $25.21 $36,894 - $56,268
2,232 Added 10.55%
23,388 $527,000
Q4 2021

Feb 14, 2022

BUY
$17.1 - $23.34 $99,351 - $135,605
5,810 Added 37.86%
21,156 $419,000
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $99,836 - $114,294
5,073 Added 49.38%
15,346 $302,000
Q2 2021

Aug 13, 2021

BUY
$19.97 - $24.43 $205,151 - $250,969
10,273 New
10,273 $226,000
Q1 2021

May 14, 2021

SELL
$23.49 - $30.56 $2.8 Million - $3.64 Million
-119,089 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$16.78 - $27.3 $1.66 Million - $2.7 Million
-98,725 Reduced 45.33%
119,089 $3.12 Million
Q3 2020

Nov 16, 2020

SELL
$12.46 - $19.98 $133,982 - $214,844
-10,753 Reduced 4.7%
217,814 $3.79 Million
Q2 2020

Aug 14, 2020

SELL
$11.0 - $18.26 $112,728 - $187,128
-10,248 Reduced 4.29%
228,567 $3.85 Million
Q1 2020

May 14, 2020

BUY
$10.11 - $14.04 $2.41 Million - $3.35 Million
238,815 New
238,815 $2.82 Million
Q4 2019

Feb 13, 2020

SELL
$12.06 - $16.96 $2.87 Million - $4.04 Million
-237,987 Closed
0 $0
Q3 2019

Nov 19, 2019

SELL
$10.41 - $14.66 $15,739 - $22,165
-1,512 Reduced 0.63%
237,987 $3.33 Million
Q3 2019

Nov 13, 2019

SELL
$10.41 - $14.66 $293,832 - $413,793
-28,226 Reduced 10.54%
239,499 $3.35 Million
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $196,460 - $256,322
-20,088 Reduced 6.98%
267,725 $3.04 Million
Q1 2019

May 14, 2019

SELL
$10.03 - $15.71 $1.83 Million - $2.86 Million
-182,176 Reduced 38.76%
287,813 $3.43 Million
Q4 2018

Feb 13, 2019

SELL
$11.29 - $17.19 $183,981 - $280,128
-16,296 Reduced 3.35%
469,989 $6.28 Million
Q3 2018

Nov 13, 2018

BUY
$12.27 - $15.65 $5.82 Million - $7.42 Million
474,155 Added 3908.94%
486,285 $6.85 Million
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $19,216 - $24,730
1,256 Added 11.55%
12,130 $188,000
Q1 2018

May 11, 2018

BUY
$14.59 - $25.5 $158,651 - $277,287
10,874 New
10,874 $182,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.25B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.